AI death predictor, China‑Nvidia spy, FDA bypass, AO3 outage

AI Death Clock drains more than hope

WIRED’s month‑long test of the Death Clock app ended with a stark observation: the service feels like it “sucks the life out of you.” The app promises a personalized mortality estimate and tips to extend lifespan. In practice, the user reported anxiety and a sense of fatalism after a single month of daily predictions.

The experience underscores a broader risk in consumer‑facing AI that quantifies existential outcomes. By converting mortality into a data point, the tool invites users to treat death as an optimization problem. The psychological cost of confronting a precise death date was not addressed in the app’s marketing. Engineers and ethicists have warned that such feedback loops can erode mental health, especially when the model’s confidence intervals are opaque.

Trump, intel, and a reported Nvidia leak to China

Ars Technica cited a report that former President Donald Trump ignored intelligence indicating a Chinese operation targeting Nvidia. The alleged spy leveraged Trump’s relationship with Nvidia founder Jensen Huang to funnel proprietary chip designs to Beijing. The source claims the espionage effort focused on advanced GPU architectures that power AI workloads.

If the claim holds, the breach represents a direct line from political patronage to corporate IP theft. The report does not provide a timeline or quantify the stolen data, but the implication is clear: high‑value semiconductor secrets can be weaponized by state actors. The incident revives concerns about supply‑chain security for AI hardware, a sector already under scrutiny for export‑control compliance.

RFK Jr. grants peptide access, sidestepping the FDA

A separate Ars Technica story noted that Robert F. Kennedy Jr. unilaterally issued an “enforcement discretion policy” for six peptide compounds popular among the MAHA community. The move effectively places the peptides outside FDA enforcement, despite the agency’s lack of approval for any therapeutic claim.

The policy creates a legal gray zone. Researchers and vendors can now market the peptides without immediate regulatory pushback, but the safety profile of the compounds remains unverified. Critics argue that bypassing the FDA undermines the agency’s role in vetting new treatments. Proponents claim the policy restores access to experimental therapies that patients deem beneficial.

AO3 outage tests the resilience of fan‑fiction archives

Engadget reported that the Archive of Our Own (AO3) went offline, with recovery expected to take weeks. The site’s data is reportedly intact, but the cause of the outage remains unknown. AO3 hosts millions of fan‑written stories, making its availability a cultural touchstone for niche communities.

The prolonged downtime highlights the fragility of large, volunteer‑run platforms. While the underlying database survived, the lack of a public incident report hampers trust. Users are left without a clear timeline for restoration, and the outage may push some creators toward alternative hosting solutions.

What to watch next

The AI Death Clock experiment suggests that mortality‑prediction services need clearer ethical guidelines before scaling. Watch for any regulatory response from the FTC or FDA regarding health‑related AI apps. In the espionage arena, monitor congressional hearings on semiconductor security; any subpoena of Nvidia executives would signal heightened scrutiny. RFK Jr.’s peptide policy may prompt the FDA to issue a formal guidance on “enforcement discretion” for unapproved compounds. Finally, AO3’s recovery timeline will reveal how effectively volunteer‑run archives can sustain prolonged technical failures. Tracking these developments will show whether the tech community can address the tension between rapid innovation and systemic risk.